P.O.T.S.

Postural Orthostatic Tachycardia Syndrome


Postural Orthostatic Tachycardia Syndrome (P.O.T.S.), is a condition that affects circulation or blood flow. POTS is a form of orthostatic intolerance, the development of symptoms that come on when standing up from a reclining position. Symptoms that may be relieved by sitting or lying back down.

There are more than 200,000 cases of POTS in the U.S. each year, most commonly affects women between the ages of 15 and 50. Symptoms of POTS often include lightheadedness, fainting, and rapid heartbeat, which are relieved by lying down again.

Mainstream diagnosis currently requires a tilt table test, which has been the gold standard of POTS diagnosis. The tilt table measures your heart rate and blood pressure as you change posture and position. However not everyone is a candidate for tilt table ANS testing.

Physio PS uses a patented algorithm provides the only means of monitoring for P.O.T.S without a tilt table, monitoring is non-invasive and can be completed in under 20 minutes

Understanding the facts about P.O.T.S.

  • Most commonly affects women between
    15 and 50 years old.
  • It impacts about
     1 out of every 100 teens
    before adulthood
  • P.O.T.S. is not rare, it is just not well-known…
    more people in the U.S.
    have P.O.T.S. than MS
  • P.O.T.S is triggered
    by dysautonomia
  • More than A MILLION
     people suffer from
    P.O.T.S. in the U.S.
  •  It takes patients an average of 4.2 years to gain an accurate diagnosis for P.O.T.S.
  • 25% of P.O.T.S. patients
    are unable to work
    or attend school
  • P.O.T.S. patients see an average of 7 doctors before an accurate diagnosis
  • There is no one-size fits all treatment for P.O.T.S., individualized care provides the best outcomes
  • P.O.T.S. can be hindering to a person’s lifestyle, however it doesn’t have to last a lifetime! With monitoring and care P.O.T.S. patients can regain their quality of life.


‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.